Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Jul 1;89(13):5971–5975. doi: 10.1073/pnas.89.13.5971

Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: putative serological marker for acute viral infection.

P J Chen 1, J T Wang 1, L H Hwang 1, Y H Yang 1, C L Hsieh 1, J H Kao 1, J C Sheu 1, M Y Lai 1, T H Wang 1, D S Chen 1
PMCID: PMC402120  PMID: 1321429

Abstract

The development of serological assays for hepatitis C virus (HCV) has made specific diagnosis possible. However, markers useful in indicating acute-phase HCV infection have not been identified. By an immunoblotting method, we characterized the IgM and IgG antibody response against HCV capsid antigen in patients with HCV infection. Among 88% of patients with acute posttransfusion hepatitis C recruited in a prospective study, there was a transient IgM antibody response. The IgM antibody appeared shortly after onset of hepatitis (average 3.7 weeks), persisted for several months (average 18 weeks), and then disappeared. In contrast, the IgG antibody persisted long-term once it appeared. Among patients with chronic hepatitis C with milder disease activities (serum aminotransferase increase above normal levels of less than 4-fold), the IgM antibody was negative in the majority (72%). In those with acute exacerbations (aminotransferase increase of greater than 10-fold), about 55% were negative for the IgM antibody. The reactivity of the IgM antibody in the rest was weaker or became negative upon further dilution of serum. The results suggest that IgM anti-capsid antibody may serve as a marker indicating acute or active HCV infection.

Full text

PDF
5974

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter H. J., Purcell R. H., Shih J. W., Melpolder J. C., Houghton M., Choo Q. L., Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989 Nov 30;321(22):1494–1500. doi: 10.1056/NEJM198911303212202. [DOI] [PubMed] [Google Scholar]
  2. Alter H. J. The hepatitis C virus and its relationship to the clinical spectrum of NANB hepatitis. J Gastroenterol Hepatol. 1990;5 (Suppl 1):78–94. doi: 10.1111/j.1440-1746.1990.tb01783.x. [DOI] [PubMed] [Google Scholar]
  3. Alter M. J., Hadler S. C., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Moyer L. A., Fields H. A., Bradley D. W. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA. 1990 Nov 7;264(17):2231–2235. [PubMed] [Google Scholar]
  4. Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
  5. Chen P. J., Lin M. H., Tu S. J., Chen D. S. Isolation of a complementary DNA fragment of hepatitis C virus in Taiwan revealed significant sequence variations compared with other isolates. Hepatology. 1991 Jul;14(1):73–78. doi: 10.1002/hep.1840140113. [DOI] [PubMed] [Google Scholar]
  6. Clemens J. M., Taskar S., Chau K., Vallari D., Shih J. W., Alter H. J., Schleicher J. B., Mimms L. T. IgM antibody response in acute hepatitis C viral infection. Blood. 1992 Jan 1;79(1):169–172. [PubMed] [Google Scholar]
  7. Di Bisceglie A. M., Goodman Z. D., Ishak K. G., Hoofnagle J. H., Melpolder J. J., Alter H. J. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology. 1991 Dec;14(6):969–974. doi: 10.1016/0270-9139(91)90113-a. [DOI] [PubMed] [Google Scholar]
  8. Gerlich W. H., Lüer W., Thomssen R. Diagnosis of acute and inapparent hepatitis B virus infections by measurement of IgM antibody to hepatitis B core antigen. J Infect Dis. 1980 Jul;142(1):95–101. doi: 10.1093/infdis/142.1.95. [DOI] [PubMed] [Google Scholar]
  9. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5547–5551. doi: 10.1073/pnas.88.13.5547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Houghton M., Weiner A., Han J., Kuo G., Choo Q. L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology. 1991 Aug;14(2):381–388. [PubMed] [Google Scholar]
  11. Hwang L. H., Tsi H. F., Liu S. T. High level expression of porcine growth hormone in Escherichia coli from an expression vector containing bacteriophage lambda PL and N gene untranslated region. Biochem Biophys Res Commun. 1990 Dec 14;173(2):711–717. doi: 10.1016/s0006-291x(05)80093-2. [DOI] [PubMed] [Google Scholar]
  12. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  13. McHutchison J. G., Kuo G., Houghton M., Choo Q. L., Redeker A. G. Hepatitis C virus antibodies in acute icteric and chronic non-A, non-B hepatitis. Gastroenterology. 1991 Oct;101(4):1117–1119. doi: 10.1016/0016-5085(91)90742-4. [DOI] [PubMed] [Google Scholar]
  14. Nasoff M. S., Zebedee S. L., Inchauspé G., Prince A. M. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5462–5466. doi: 10.1073/pnas.88.12.5462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Okamoto H., Okada S., Sugiyama Y., Yotsumoto S., Tanaka T., Yoshizawa H., Tsuda F., Miyakawa Y., Mayumi M. The 5'-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med. 1990 Jun;60(3):167–177. [PubMed] [Google Scholar]
  16. Omata M., Yokosuka O., Takano S., Kato N., Hosoda K., Imazeki F., Tada M., Ito Y., Ohto M. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet. 1991 Oct 12;338(8772):914–915. doi: 10.1016/0140-6736(91)91774-o. [DOI] [PubMed] [Google Scholar]
  17. Quiroga J. A., Campillo M. L., Catillo I., Bartolomé J., Porres J. C., Carreño V. IgM antibody to hepatitis C virus in acute and chronic hepatitis C. Hepatology. 1991 Jul;14(1):38–43. doi: 10.1002/hep.1840140107. [DOI] [PubMed] [Google Scholar]
  18. Scully L. J., Brown D., Lloyd C., Shein R., Thomas H. C. Immunological studies before and during interferon therapy in chronic HBV infection: identification of factors predicting response. Hepatology. 1990 Nov;12(5):1111–1117. doi: 10.1002/hep.1840120506. [DOI] [PubMed] [Google Scholar]
  19. Sjogren M., Hoofnagle J. H. Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis. Gastroenterology. 1985 Aug;89(2):252–258. doi: 10.1016/0016-5085(85)90323-3. [DOI] [PubMed] [Google Scholar]
  20. Van der Poel C. L., Cuypers H. T., Reesink H. W., Weiner A. J., Quan S., Di Nello R., Van Boven J. J., Winkel I., Mulder-Folkerts D., Exel-Oehlers P. J. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet. 1991 Feb 9;337(8737):317–319. doi: 10.1016/0140-6736(91)90942-i. [DOI] [PubMed] [Google Scholar]
  21. Wang T. H., Wang J. T., Lin J. T., Sheu J. C., Sung J. L., Chen D. S. A prospective study of posttransfusion hepatitis in Taiwan. J Hepatol. 1991 Jul;13(1):38–43. doi: 10.1016/0168-8278(91)90861-5. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES